171 related articles for article (PubMed ID: 6214988)
1. Comparative pharmacokinetics of cefoperazone and cefamandole.
Srinivasan S; Francke EL; Neu HC
Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
[TBL] [Abstract][Full Text] [Related]
2. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
Neu HC
Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
Armstrong GC; Wise R; Brown RM; Hancox J
Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of ceftizoxime compared with that of cefamandole.
Neu HC; Srinivasan S
Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
Neu HC
J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefamandole in patients with renal impairment.
Czerwinski AW; Pederson JA
Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
[TBL] [Abstract][Full Text] [Related]
10. Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.
Boscia JA; Korzeniowski OM; Snepar R; Kobasa WD; Levison ME; Kaye D
Antimicrob Agents Chemother; 1983 Mar; 23(3):385-9. PubMed ID: 6221691
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ceforanide.
Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
[TBL] [Abstract][Full Text] [Related]
12. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
Lee FH; Smyth RD; Van Harken DR
Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
Bolton WK; Scheld WM; Spyker DA; Sande MA
Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
[TBL] [Abstract][Full Text] [Related]
14. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
Guerrini VH; Filippich LJ; Cao GR; English PB; Bourne DW
J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of cefamandole in newborn infants.
Agbayani MM; Khan AJ; Kemawikasit P; Rosenfeld W; Salazar D; Kumar K; Glass L; Evans HE
Antimicrob Agents Chemother; 1979 May; 15(5):674-6. PubMed ID: 525985
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
Greenfield RA; Gerber AU; Craig WA
Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefamandole in patients with renal failure.
Meyers BR; Hirschman SZ
Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
